Last updated on March 2019

European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pulmonary Alveolar Proteinosis | respiratory distress syndrome of newborn | Child | Interstitial lung disease | Pulmonary Fibrosis | Pulmonary Eosinophilia
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • all children with suspected or
  • verified diagnosis of ILD or
  • masquerading as ILD and
  • those with rare localized parenchymal lung diseases

Exclusion Criteria:

  • other indication as inclusion criteria

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.